Last year's American Association for Clinical Chemistry annual meeting saw announcements by several major mass spectrometry and in vitro diagnostic players regarding their plans to develop clinical mass spec platforms.

A year later, some of those plans have progressed to concrete realities as both Sciex and Thermo Fisher Scientific have clinical instruments up and running in customer labs.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.